Interview with Gabriele Grom, Managing Director, Merck Sharp & Dohme…
You have been the head of MSD’s Austrian operations since April 2009. Can you start by telling our readers about the evolution of the affiliate since the merger with Schering…
Address: EURO PLAZA Building G 5th Floor, Am Euro Platz 2, 1120 Vienna,Austria
Tel: +43 1/260 440
Web: http://www.msd.at/
From developing new therapies that treat and prevent disease to helping people in need, we’re committed to improving health and well-being around the world.
Our vision is to make a difference in the lives of people globally through our innovative medicines, vaccines, biologic therapies, consumer health and animal products. We aspire to be the best healthcare company in the world and are dedicated to providing leading innovations and solutions for tomorrow.
We have made it our mission to provide innovative, distinctive products and services that save and improve lives, satisfy customer needs and to be recognized as a great place to work.
MSD is committed to operating in Austria for improving the understanding of health of the local population
organized by the Austrian branch constantly training sessions for doctors and medical staff and funded medical research projects and research awards
MSD Austria has set up online services univadis ® and docvadis ® to support physicians in their daily work
You have been the head of MSD’s Austrian operations since April 2009. Can you start by telling our readers about the evolution of the affiliate since the merger with Schering…
Dr Spatz, what would you highlight as the main specificities of the Austrian generic market, and explain how Teva has adapted its approach to the Austrian environment? Teva recently changed…
Dr. Nikitsch, you started Menarini’s Austrian operations almost 13 years ago. Would you say that Menarini’s presence in Austria today reflects the vision you had for the company in Austria…
Can you give our readers a snapshot of Austroplant’s scope of activities and its structure in Austria and the central European market? Austroplant/Dr Peithner belongs to the Schwabe Group, the…
Just like other European countries, Austria is in the search for meaningful savings in healthcare. Austria’s increasingly price sensitive pharma market is seeing the rise of generic medicines gaining market…
Whereas most General Managers are exposed to different countries during their professional career, you have chosen to dedicate yours to the Austrian market. What is it in this country so…
You have been General Secretary of PHARMIG since 2004 and have witnessed the market’s development over the past 8 years. What have been the most important changes since you started…
See our Cookie Privacy Policy Here
